Icosavax
is a Washington-based biotechnology company that researches and develops VLP vaccines for the treatment of respiratory diseases... Read moreIcosavax
is a Washington-based biotechnology company that researches and develops VLP vaccines for the treatment of respiratory diseases... Read more
News
Feb 20, 2024
Sharecast
Icosavax: AstraZeneca acquires US-based biopharmaceutical company
Feb 20, 2024
The Business Journals: Seattle
Icosavax: AstraZeneca completes $1.1B acquisition of UW spinout Icosavax
Jan 03, 2024
MarketScreener
Icosavax: ICVX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Icosavax, Inc. Is Fair to Shareholders
Dec 15, 2023
MarketScreener
Icosavax: ICOSAVAX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Icosavax, Inc. - ICVX
Dec 13, 2023
MarketScreener
Icosavax: SHAREHOLDER NEWS: Johnson Fistel Investigates Proposed Sale of Icosavax; Is the Deal in the Best Interest of Shareholders?
Dec 13, 2023
BizPlus
Icosavax: AstraZeneca in 875m swoop on US vaccine firm
Dec 13, 2023
Beckers Hospital Review
Icosavax: AstraZeneca to buy vaccine company for $1.1B
Dec 13, 2023
MedCity News
Icosavax: AstraZeneca's Icosavax M&A Deal Helps It Stand Out in Multivalent Vaccines Chase
Dec 12, 2023
StreetInsider
Press Release: Icosavax : Icosavax Announces Positive Topline Interim Phase 2 Results for Combination VLP Vaccine Candidate IVX-A12 Against RSV and hMPV in Older Adults
Dec 12, 2023
Proactive Investors
Icosavax: Icosavax surges 45% in pre-market trading as AstraZeneca agrees takeover
Icosavax Competitors
1
2
3
4
5
6
7
8
9
10